Nasal Steroids for Perennial Allergic Rhinitis: Is PRN Use Enough? - Frankly Speaking Ep 235

<p style="margin: 0in; font-family: Calibri; font-size: 11.0pt;"> Credits: 0.25 AMA PRA Category 1 Credit™</p> <p style="margin: 0in; font-family: Calibri; font-size: 11.0pt;">  </p> <p style="margin: 0in; font-family: Calibri; font-size: 11.0pt;"> CME/CE Information and Claim Credit: <a href= "https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-208" target="_blank" rel= "noopener">https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-235</a></p> <p style="margin: 0in; font-family: Calibri; font-size: 11.0pt;">  </p> <p style="margin: 0in; font-family: Calibri; font-size: 11.0pt;"> Overview: Perennial allergic rhinitis affects both children and adults, and management includes both allergy avoidance as well as medication management. Intranasal steroids are the mainstay of treatment and have traditionally required consistent use, but new data are emerging. Find out the results of a new study evaluating PRN use as an alternative approach.</p> <p style="margin: 0in; font-family: Calibri; font-size: 11.0pt;">  </p> <p style="margin: 0in; font-family: Calibri; font-size: 11.0pt;"> Episode resource links:</p> <ul> <li style="font-family: Calibri; font-size: 11pt;">Thongngarm T, Wongsa C, Phinyo P, Assanasen P, Tantilipikorn P, Sompornrattanaphan M. As-Needed Versus Regular Use of Fluticasone Furoate Nasal Spray in Patients with Moderate to Severe, Persistent, Perennial Allergic Rhinitis: A Randomized Controlled Trial. J Allergy Clin Immunol Pract. 2021 Mar;9(3):1365-1373</li> </ul> <p style="margin: 0in; font-family: Calibri; font-size: 11.0pt;"> Guest: Alan Ehrlich MD, FAAFP</p> <p style="margin: 0in; font-family: Calibri; font-size: 11.0pt;">  </p> <p style="margin: 0in; font-family: Calibri; font-size: 11.0pt;"> Music Credit: Richard Onorato</p>